CN115463200A - Traditional Chinese medicine composition and patch for treating adenoidal hypertrophy and preparation method thereof - Google Patents
Traditional Chinese medicine composition and patch for treating adenoidal hypertrophy and preparation method thereof Download PDFInfo
- Publication number
- CN115463200A CN115463200A CN202211369749.4A CN202211369749A CN115463200A CN 115463200 A CN115463200 A CN 115463200A CN 202211369749 A CN202211369749 A CN 202211369749A CN 115463200 A CN115463200 A CN 115463200A
- Authority
- CN
- China
- Prior art keywords
- parts
- patch
- hypertrophy
- treating
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000003462 adenoid hypertrophy Diseases 0.000 title claims abstract description 66
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 18
- 206010001229 Adenoidal hypertrophy Diseases 0.000 title claims description 9
- 238000011282 treatment Methods 0.000 claims abstract description 31
- 244000197580 Poria cocos Species 0.000 claims abstract description 23
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 23
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 21
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 21
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 21
- 239000011425 bamboo Substances 0.000 claims abstract description 21
- 241000132012 Atractylodes Species 0.000 claims abstract description 20
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 20
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 20
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 20
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 17
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 17
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 17
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 17
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 241000237502 Ostreidae Species 0.000 claims abstract description 11
- 235000020636 oyster Nutrition 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims abstract description 5
- 244000082204 Phyllostachys viridis Species 0.000 claims abstract 5
- 210000002534 adenoid Anatomy 0.000 claims description 45
- 239000000843 powder Substances 0.000 claims description 28
- 206010020880 Hypertrophy Diseases 0.000 claims description 16
- 241000218378 Magnolia Species 0.000 claims description 16
- 239000002674 ointment Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 9
- 235000012907 honey Nutrition 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 6
- 240000007185 Albizia julibrissin Species 0.000 claims description 5
- 241000801118 Lepidium Species 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 241000721047 Danaus plexippus Species 0.000 claims description 3
- 244000081426 Ranunculus ficaria Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002357 osmotic agent Substances 0.000 claims 1
- 238000001467 acupuncture Methods 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 16
- 235000014375 Curcuma Nutrition 0.000 abstract description 14
- 244000164480 Curcuma aromatica Species 0.000 abstract description 14
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract description 14
- 208000024891 symptom Diseases 0.000 abstract description 13
- 206010041235 Snoring Diseases 0.000 abstract description 5
- 210000003928 nasal cavity Anatomy 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 238000009423 ventilation Methods 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000003860 sleep quality Effects 0.000 abstract description 3
- 230000003340 mental effect Effects 0.000 abstract description 2
- 241000321096 Adenoides Species 0.000 description 26
- 210000001989 nasopharynx Anatomy 0.000 description 19
- 241001330002 Bambuseae Species 0.000 description 16
- 238000003745 diagnosis Methods 0.000 description 12
- 241001530126 Scrophularia Species 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 235000001188 Peltandra virginica Nutrition 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 210000001983 hard palate Anatomy 0.000 description 2
- 201000000615 hard palate cancer Diseases 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004086 maxillary sinus Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 210000003718 sphenoid sinus Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 208000020985 infant symptom Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 210000001154 skull base Anatomy 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating adenoid hypertrophy, and belongs to the technical field of traditional Chinese medicines for treating adenoid hypertrophy. The composition comprises the following components in parts by weight: 15-25 parts of radix scrophulariae, 15-25 parts of fried bighead atractylodes rhizome, 20-35 parts of poria cocos, 15-30 parts of curcuma zedoary, 15-30 parts of rhizoma acori graminei, 20-35 parts of charred medicated leaven, 10-25 parts of bamboo shavings, 10-25 parts of semen lepidii, 10-25 parts of rhizoma alismatis, 10-30 parts of scutellaria baicalensis, 10-25 parts of flos magnoliae, 20-35 parts of salvia miltiorrhiza, 15-30 parts of cortex albiziae, 15-30 parts of raw oyster and 15-20 parts of lance asiabell root. The invention adds a new means of conservative treatment of adenoid hypertrophy, directly pastes the patch on the corresponding acupuncture point of the child patient, is economical and practical, has simple use, no side effect and good effect, effectively avoids the habit of more movement and less silence of the child, relieves the mental pressure and the psychological fear of the child in traditional Chinese medicine, ensures the normal proceeding of treatment, enhances the treatment effect, relieves the uncomfortable symptoms of the child patient, enhances the ventilation of nasal cavity, eliminates the snoring caused by adenoid hypertrophy and improves the sleep quality of the child patient.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines for treating adenoid hypertrophy, and particularly relates to a traditional Chinese medicine composition and a patch for treating adenoid hypertrophy and a preparation method thereof.
Background
The adenoid body is also called as pharyngeal tonsil or proliferous body, and the adenoid body grows with the age of the infant, the adenoid body grows maximally between 4 and 6 years old, gradually shrinks after puberty and disappears after adulthood. The corresponding symptoms caused by adenoid hyperplasia hypertrophy, such as long-term nasal obstruction, sleep obstruction, obstructive nasal voice during speaking, and nasal discharge increase, are called adenoid hyperplasia or adenoid hypertrophy. Adenoid hypertrophy is very common in the clinic, and untimely treatment of the disease can cause many complications, such as: affecting the face, causing tracheitis, causing the reaction retardation of children, affecting the growth and development, etc.
In the prior art, the treatment method for the hypertrophy of the adenoid bodies of children mainly comprises operation treatment, medicament treatment and conservative treatment, wherein the operation treatment is to remove the adenoid bodies, the method has quick response and high cost, the immunity is reduced after the adenoid bodies are removed by the children, respiratory diseases are easily infected, and the operation needs general anesthesia and has certain risk; most of the drug therapies are oral antibiotics, hormones or nasal sprays and the like, although the drug therapies can relieve symptoms, long-term therapy is needed, the drug tolerance of children is poor, the drug therapies have side effects, and the side effects on the children are large after long-term treatment. Therefore, more and more parents of children patients want to perform conservative treatment, relieve symptoms through clinical operations such as acupuncture, nose fumigation by traditional Chinese medicines, massage and the like, improve the immunity of the organisms of children, and ensure that adenoids shrink along with the growth of the ages, but the children patients are small in age, move more and less, are not pain-resistant, do not want to cooperate with each other, and therefore the treatment effect is poor.
Disclosure of Invention
The invention aims to solve the problems that the existing barriers for adenoid therapy, including surgical therapy, have high risk and are easy to infect respiratory diseases; the traditional Chinese medicine composition and the patch for treating adenoidal hypertrophy and the preparation method thereof are provided for treating the defects of large side effect of the medicine treatment and the like and poor treatment effects of acupuncture, massage, nose fumigation by traditional Chinese medicines and the like. The traditional Chinese medicine composition and the patch have no side effect, are economical and practical, are simple to use, can eliminate adenoid hypertrophy, relieve symptoms of a child patient, enhance nasal ventilation, eliminate snore caused by the adenoid hypertrophy and improve sleep quality of the child patient.
The inventor of the application realizes that the disease is mainly caused by 'phlegm', and the phlegm is a pathological product formed by the metabolic disturbance of body water. The spleen of children is often insufficient, once improper diet often causes dampness accumulation and phlegm generation, the phlegm is smeared on the lung, so that the lung is difficult to open, the lung opens into the nose, exogenous pathogenic factors attack the nasopharynx firstly and then attack the lung, and the phlegm fails to disperse in time, the phlegm is often retained at the nasopharynx juncture, the lung fails to disperse and descend, phlegm turbidity stays, stagnation and nucleation accumulates in the nasopharynx, and adenoid hypertrophy occurs. The inventor of the application thinks that the treatment adopts the major methods of nourishing yin, strengthening the spleen, eliminating dampness, harmonizing the stomach, freeing nasal orifices and dissipating stagnation, relieves the symptoms of the children patients and enhances the nasal ventilation. The action mechanism of the invention is to strengthen the spleen, eliminate dampness and harmonize the stomach; promoting blood circulation, removing blood stasis, clearing away heat and toxic materials, softening hard masses, and resolving hard mass; it is suitable for relieving nasal cavity, resolving hard mass and stopping snore; the constitution of the children patient can be regulated and the adenoid can be reduced through the three-step treatment mechanism.
In order to realize the purpose, the invention adopts the following technical scheme:
a traditional Chinese medicine composition for treating adenoidal hypertrophy comprises the following components in parts by weight: 15-25 parts of radix scrophulariae, 15-25 parts of fried bighead atractylodes rhizome, 20-35 parts of poria cocos, 15-30 parts of curcuma zedoary, 15-30 parts of rhizoma acori graminei, 20-35 parts of charred medicated leaven, 10-25 parts of bamboo shavings, 10-25 parts of semen lepidii, 10-25 parts of rhizoma alismatis, 10-30 parts of scutellaria baicalensis, 10-25 parts of flos magnoliae, 20-35 parts of salvia miltiorrhiza, 15-30 parts of cortex albiziae, 15-30 parts of raw oyster and 15-20 parts of lance asiabell root.
As a further improvement of the technical scheme, the traditional Chinese medicine composition for treating adenoid hypertrophy takes the fried bighead atractylodes rhizome, the tuckahoe, the figwort root and the lance asiabell root as monarch drugs; the rhizoma acori graminei, the scorched medicated leaven, the bamboo shavings, the pepperweed seeds and the rhizoma alismatis are taken as ministerial drugs; the scutellaria baicalensis and the magnolia flower are used as adjuvant drugs; the salvia miltiorrhiza, the silktree albizzia bark, the zedoary and the raw oyster shell are taken as adjuvant medicaments.
As a further improvement of the technical scheme, the traditional Chinese medicine composition for treating adenoid hypertrophy comprises the following components in parts by weight: 20 parts of radix scrophulariae, 23 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae, 22 parts of raw oyster and 18 parts of lance asiabell root.
The invention also provides a patch for treating adenoid hypertrophy, which comprises the traditional Chinese medicine composition for treating adenoid hypertrophy.
As a further improvement of the technical scheme, the patch for treating adenoid hypertrophy is used for being applied to one or more acupuncture points of Yongquan, shenque, tiantu and Dazhui of a patient.
The invention also provides a preparation method of the patch for treating adenoid hypertrophy, which comprises the following steps:
s1: respectively and independently crushing figwort root, fried bighead atractylodes rhizome, poria cocos, curcuma zedoary, rhizoma acori graminei, scorched medicated leaven, bamboo shavings, semen lepidii, rhizoma alismatis, scutellaria baicalensis, magnolia flower, salvia miltiorrhiza, cortex albiziae, raw oyster shell and lance asiabell root into 80-mesh medicinal powder for later use;
s2: pulverizing the powder in S1 to 200-400 mesh powder with a low-temperature ultrafine pulverizer for later use;
s3: uniformly mixing the medicinal powder in the step S2 to form ointment;
s4: and (4) coating the ointment in the step (S3) on a backing material, cutting into slices, covering a protective film on the slices, and packaging to obtain the patch.
As a further improvement of the technical scheme, the preparation method of the patch for treating adenoid hypertrophy further comprises the following steps of adding pure honey: pure honey is also added in the S3, and the honey is added into the medicine powder and mixed evenly.
As a further improvement of the technical proposal, the preparation method of the patch for treating adenoid hypertrophy further adds a penetrating agent; and S3, adding a penetrating agent into the medicinal powder, and uniformly mixing.
As a further improvement of the technical proposal, the penetrant in the preparation method of the patch for treating adenoid hypertrophy is azone.
The clinical treatment conditions of the traditional Chinese medicine composition and the patch in 2020 to 2022 are detailed as follows:
1. overview of the infant: selecting the items of medical history, illness state, age and original treatment method.
2. The source of the infant patients is as follows: the patients in comprehensive hospitals and specialized outpatient hospitals in the south and north of China.
3. Case inclusion criteria: according to the age and pathological characteristics of adenoid hypertrophy patients, the gender and age are not limited, and various other medicaments and treatment modes for treating adenoid hypertrophy are stopped before treatment.
4. The treatment method comprises the following steps:
prescription: 20 parts of radix scrophulariae, 23 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae, 22 parts of raw oyster and 18 parts of lance asiabell root;
the preparation method comprises the following steps: s1: weighing raw materials of the traditional Chinese medicine composition for treating adenoid hypertrophy in corresponding parts by weight, and independently crushing the raw materials into 80-mesh medicinal powder by using a crusher respectively for later use;
s2: pulverizing the medicinal powder in the step S1 into 200-mesh medicinal powder by using a low-temperature ultrafine pulverizer for later use;
s3: adding pure honey into the medicinal powder in the S2, adding azone, and uniformly mixing to obtain an ointment;
s4: coating the ointment in the step S3 on a backing material, cutting into slices, covering a protective film on each slice, and packaging to obtain the patch, wherein the weight of each slice is 4 g;
the using method comprises the following steps: the patch is applied to one or more acupuncture points of Yongquan, shenque acupoint, tiantu and Dazhui acupoint for 8-12 hr, 10 days with one patch and three patches for one treatment course.
5. And (3) evaluating the curative effect:
remarkably: the adenoid regress;
the method has the following advantages: adenoids have a tendency to regress;
and (4) invalidation: the change before and after treatment is not large;
6. and (3) analyzing the curative effect:
265 patients with adenoid hypertrophy, 79 patients with significant adenoid hypertrophy, 88 patients with moderate hypertrophy and 98 patients with mild hypertrophy are treated together according to the group entry standard;
the course of the disease is as follows: 102 cases within 1 month, 83 cases within 1 month to 2 months, 56 cases within 2 months to 3 months, and 24 cases over 3 months;
age group: 57 cases at 2-4 years old, 94 cases at 4-6 years old, 61 cases at 6-8 years old, 33 cases at 8-10 years old, and 20 cases at 10-12 years old;
the types and curative effects of the diseases are shown in table 1, and the administration time is three treatment courses.
TABLE 1
Compared with the prior art, the invention has the following beneficial effects:
1. the traditional Chinese medicine composition can regulate the physique of a child patient, has the effects of resisting inflammation and relieving swelling, eliminates the fat adenoid body of the child patient and relieves the symptom of the fat adenoid body of the child patient.
2. Increase the new means of the hypertrophy of adenoid body conservative therapy, directly apply patch paste on infant's corresponding acupuncture point, it is economical and practical, simple to use, the no side effect, it is effectual, effectively avoid children's habit of moving more and quietly less, alleviate infant's mental pressure and to the psychological fear of traditional chinese medical science, guarantee going on of treatment, reinforcing treatment, alleviate infant's symptom, the reinforcing nasal cavity is ventilated, eliminates snore because of the hypertrophy of adenoid body, and then improves infant's sleep quality.
3. The patch provided by the invention has an obvious effect on treating adenoid hypertrophy, wherein the effective rate of the adenoid hypertrophy reaches 96.20%, the significant rate is 89.87%, the inefficiency is only 3.80%, the effective rate of the adenoid moderate hypertrophy reaches 97.83%, the significant rate is 94.32%, the inefficiency is only 2.27%, the effective rate of the adenoid mild hypertrophy reaches 100%, and the significant rate reaches 100%.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the invention thereto. The experimental methods for specific adjustments not noted in the following examples were selected according to commercial instructions. All other embodiments, which can be derived by a person skilled in the art from the described embodiments of the invention without inventive step, are within the scope of protection of the invention. Unless defined otherwise, technical or scientific terms used herein shall have the ordinary meaning as understood by one of ordinary skill in the art to which this invention belongs.
In the following examples, parched white atractylodes rhizome, tuckahoe, figwort root and lance asiabell root are all used as monarch drugs; rhizoma acori graminei, charred medicated leaven, bamboo shavings, semen lepidii and rhizoma alismatis are taken as ministerial drugs; radix Scutellariae and flos Magnoliae are used as adjuvant drugs; radix Salviae Miltiorrhizae, cortex Albizziae, rhizoma Curcumae, and Concha Ostreae are used as adjuvant drugs.
Example 1:
a traditional Chinese medicine composition for treating adenoidal hypertrophy comprises the following components in parts by weight: 15 parts of radix scrophulariae, 15 parts of fried bighead atractylodes rhizome, 20 parts of poria cocos, 15 parts of curcuma zedoary, 15 parts of rhizoma acori graminei, 20 parts of charred medicated leaven, 10 parts of bamboo shavings, 10 parts of semen lepidii, 10 parts of rhizoma alismatis, 10 parts of scutellaria baicalensis, 10 parts of magnolia flower, 20 parts of salvia miltiorrhiza, 15 parts of cortex albiziae, 15 parts of raw oyster and 15 parts of lance asiabell root;
the patch for treating adenoid hypertrophy comprises the traditional Chinese medicine composition for treating adenoid hypertrophy;
the preparation method of the patch for treating adenoid hypertrophy comprises the following steps:
s1: the figwort root, the fried largehead atractylodes rhizome, the tuckahoe, the zedoary, the grassleaf sweelflag rhizome, the scorched medicated leaven, the bamboo shavings, the pepperweed seed, the oriental waterplantain rhizome, the baical skullcap root, the biond magnolia flower, the salvia miltiorrhiza, the silktree albizzia bark, the raw oyster shell and the lance asiabell root in corresponding parts by weight are respectively and independently crushed into 80-mesh medicinal powder for later use;
s2: pulverizing the powder in S1 to 200-400 mesh powder with a low-temperature ultrafine pulverizer for later use;
s3: adding pure honey into the medicinal powder in the S2, adding azone, and uniformly mixing to obtain an ointment;
s4: and (4) coating the ointment in the step (S3) on a backing material, cutting into slices, covering a protective film on each slice, and packaging to obtain the patch, wherein the weight of each patch of the ointment is 4 g.
The patch for treating adenoid hypertrophy, which is prepared by adopting the raw material proportion and the method, is applied to one or more acupuncture points of Yongquan, shenque acupuncture point, tiantu and Dazhui acupuncture point of a patient, and the patch is used for permeating the acupuncture points of Yongquan, shenque acupuncture point, tiantu, dazhui acupuncture point and the like and being pasted for 8 to 12 hours, so that the effects of guiding fire to descend, nourishing yin and strengthening spleen, eliminating dampness and harmonizing stomach, freeing nasal orifices, clearing heat and removing toxicity and dissipating stagnation are achieved, the symptoms of a child patient are relieved, the ventilation of a nasal cavity is enhanced, snoring caused by adenoid hypertrophy is eliminated, and the sleep treatment of the child is improved.
Example 2:
a traditional Chinese medicine composition for treating adenoid hypertrophy comprises the following components in parts by weight: 15 parts of figwort root, 15 parts of fried largehead atractylodes rhizome, 20 parts of poria cocos, 15 parts of curcuma zedoary, 15 parts of grassleaf sweelflag rhizome, 20 parts of scorched medicated leaven, 10 parts of bamboo shavings, 10 parts of pepperweed seed, 10 parts of oriental waterplantain rhizome, 10 parts of baical skullcap root, 10 parts of magnolia flower, 20 parts of salvia miltiorrhiza, 15 parts of silktree albizzia bark, 15 parts of raw oyster shell and 15 parts of lance asiabell root;
the patch for treating adenoid hypertrophy comprises the traditional Chinese medicine composition for treating adenoid hypertrophy;
the preparation method of the patch for treating adenoid hypertrophy comprises the following steps:
s1: respectively and independently crushing figwort root, fried bighead atractylodes rhizome, poria cocos, curcuma zedoary, rhizoma acori graminei, scorched medicated leaven, bamboo shavings, semen lepidii, rhizoma alismatis, scutellaria baicalensis, magnolia flower, salvia miltiorrhiza, cortex albiziae, raw oyster shell and lance asiabell root into 80-mesh medicinal powder for later use;
s2: pulverizing the medicinal powder in the step S1 into 200-mesh medicinal powder by using a low-temperature ultrafine pulverizer for later use;
s3: adding pure honey into the medicinal powder in the S2, adding azone, and uniformly mixing to obtain an ointment;
s4: and (4) coating the ointment in the step (S3) on a backing material, cutting into slices, covering a protective film on each slice, and packaging to obtain the patch, wherein the weight of each slice is 4 g.
The patch for treating adenoid hypertrophy, which is prepared by adopting the raw material proportion and the method, is applied to one or more acupuncture points of Yongquan, shenque acupuncture point, tiantu and Dazhui acupuncture point of a patient, and the acupuncture points of Yongquan, shenque acupuncture point, tiantu, dazhui acupuncture point and the like are penetrated by the patch and applied for 8 to 12 hours.
Example 3:
a traditional Chinese medicine composition for treating adenoid hypertrophy comprises the following components in parts by weight: 20 parts of radix scrophulariae, 23 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae, 22 parts of raw oyster and 18 parts of lance asiabell root;
the patch for treating adenoid hypertrophy comprises the traditional Chinese medicine composition for treating adenoid hypertrophy;
the preparation method of the patch for treating adenoid hypertrophy comprises the following steps:
s1: respectively and independently crushing figwort root, fried bighead atractylodes rhizome, poria cocos, curcuma zedoary, rhizoma acori graminei, scorched medicated leaven, bamboo shavings, semen lepidii, rhizoma alismatis, scutellaria baicalensis, magnolia flower, salvia miltiorrhiza, cortex albiziae, raw oyster shell and lance asiabell root into 80-mesh medicinal powder for later use;
s2: crushing the medicinal powder in the step S1 into 400-mesh medicinal powder by using a low-temperature ultrafine grinder for later use;
s3: adding pure honey into the medicinal powder in the S2, adding azone, and uniformly mixing to obtain an ointment;
s4: and (4) coating the ointment in the step (S3) on a backing material, cutting into slices, covering a protective film on each slice, and packaging to obtain the patch, wherein the weight of each patch of the ointment is 4 g.
The patch for treating adenoid hypertrophy, which is prepared by adopting the raw material proportion and the method, is applied to one or more acupuncture points of Yongquan, shenque acupuncture point, tiantu and Dazhui acupuncture point of a patient, and the acupuncture points of Yongquan, shenque acupuncture point, tiantu, dazhui acupuncture point and the like are penetrated by the patch and applied for 8 to 12 hours.
Comparative example 1:
a traditional Chinese medicine composition for treating adenoidal hypertrophy comprises the following components in parts by weight: 20 parts of radix scrophulariae, 30 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of flos magnoliae, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae, 22 parts of raw oyster and 18 parts of lance asiabell root; a patch for treating adenoid hypertrophy, which comprises the traditional Chinese medicine composition for treating adenoid hypertrophy; the specific preparation method is the same as that in example 3, compared with example 3, the externally applied patch prepared without adding the fried bighead atractylodes rhizome has poor curative effect, slow adenoid body fading speed and lower recovery degree after being used by a child patient.
Comparative example 2:
a traditional Chinese medicine composition for treating adenoid hypertrophy comprises the following components in parts by weight: 20 parts of radix scrophulariae, 23 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae and 22 parts of raw oyster; the patch for treating adenoid hypertrophy comprises the traditional Chinese medicine composition for treating adenoid hypertrophy; compared with the embodiment 3, the preparation method of the externally applied patch has the advantages that the externally applied patch prepared by removing the lance asiabell root has little curative effect after being used by a child patient, no fading trend of adenoids, no relief of symptoms such as excessive phlegm, nasal obstruction and the like.
Comparative example 3:
a traditional Chinese medicine composition for treating adenoidal hypertrophy comprises the following components in parts by weight: 15 parts of radix scrophulariae, 23 parts of fried bighead atractylodes rhizome, 35 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae, 22 parts of raw oyster and 18 parts of lance asiabell root; the patch for treating adenoid hypertrophy comprises the traditional Chinese medicine composition for treating adenoid hypertrophy; compared with the embodiment 3, the specific preparation method reduces the dosage of the figwort root to 15 parts and increases the dosage of the tuckahoe to 35 parts from 20 parts compared with the embodiment 3, and the prepared external patch has the advantages that the treatment effect of the sick children is obviously reduced after the application, adenoids tend to fade and the discomfort symptom is less relieved.
Comparative example 4:
a traditional Chinese medicine composition for treating adenoid hypertrophy comprises the following components in parts by weight: 25 parts of figwort root, 23 parts of fried largehead atractylodes rhizome, 20 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of grassleaf sweelflag rhizome, 30 parts of scorched medicated leaven, 18 parts of bamboo shavings, 19 parts of pepperweed seed, 22 parts of oriental waterplantain rhizome, 26 parts of baical skullcap root, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of silktree albizzia bark, 22 parts of raw oyster shell and 18 parts of lance asiabell root; a patch for treating adenoid hypertrophy, which comprises the traditional Chinese medicine composition for treating adenoid hypertrophy; the specific preparation method is the same as example 3, compared with example 3, the dosage of figwort is increased from 20 parts to 25 parts, and the dosage of tuckahoe is decreased from 30 parts to 20 parts, and the prepared external patch can be used for eliminating adenoids of children after use, but two treatment courses are increased.
Typical cases are:
it should be noted that the measurement of the A/N ratio in the following typical cases is the most commonly used method in clinic at present, and can well reflect the size of adenoids and the degree of the adenoids occupying the airway of the nasopharyngeal cavity.
Adenoid (a) thickness: the vertical distance from the most protruded point of the adenoid body to the lateral side of the occipital slope skull is the thickness of the adenoid body;
nasopharyngeal cavity (nasopharyngel, N) width: the distance from the rear end of the hard palate to the intersection point of the wing plate and the skull base is the width of the nasopharyngeal cavity. N is the width of the nasopharynx cavity of the most convex part of the adenoid body, namely the vertical distance between the intersection point of the reverse extension line of the vertical line and the upper edge of the rear end of the hard palate or the front middle part of the soft palate and the external tangent line of the occipital slope cranium; measurement of A/N ratio:
the ratio of the two is less than or equal to 0.60 in normal conditions;
mild hypertrophy at a ratio of 0.61-0.70;
the ratio is more than or equal to 0.71, and the patients are moderately hypertrophic;
adenoids are significantly hypertrophied > 0.80.
Clinical case 1:
when the patient is diagnosed with adenoid by 6-menstruation lateral nasopharynx tablet in 2020, the diagnosis detail report shows that the posterior wall of nasopharynx top is thickened and the corresponding airway is slightly narrowed. The ratio (A/N ratio) of the distance between the outer edge of the slope and the most convex point of the pharyngeal posterior wall to the distance between the outer edge of the slope and the front edge of the airway is 0.87. The patient uses the patch prepared in the embodiment 3 of the invention at night, the diagnosis is in detail reported that the back wall of the nasopharynx top is thickened, the corresponding airway is slightly narrowed, the ratio of the distance between the most convex point of the slope outer edge and the back wall of the nasopharynx to the distance between the slope outer edge and the front edge of the airway is 0.65, the A/N ratio is from 0.87 to 0.65, the adenoid body is changed from obvious hypertrophy to slight hypertrophy, and the symptom is relieved after 3 months to an outpatient service and 9 months of examination of the nasopharynx side tablet in 2020.
Clinical case 2:
the lateral nasopharynx of 8 months of department outpatient department of otorhinolaryngology of some hospitals in Shanxi, 8 years of Liu Ji, male, confirmed diagnosis as that adenoid body is obviously hypertrophied, and its diagnosis is reported in detail as that the back wall of nasopharynx top is thickened, corresponding airway is slightly narrowed, and the ratio (A/N ratio) of the distance from the outer edge of the slope to the most salient point of the back wall of pharynx to the distance from the outer edge of the slope to the front edge of airway is 1.0. After the patient uses the patch prepared in the embodiment 3 of the invention, the patient goes to the hospital for a further diagnosis 2 months later and is examined on the nasopharynx lateral tablet 10 months in 2020, the diagnosis detailed report is that the nasopharynx top back wall is thickened, the corresponding airway is slightly narrowed, and the ratio of the distance between the slope outer edge and the nasopharynx back wall most salient point to the distance between the slope outer edge and the airway front edge is 0.75. Although adenoids are still diagnosed as hypertrophied, the A/N ratio of the patch prepared in example 3 of the present invention is from 1.0 to 0.75, and adenoids are changed from significant hypertrophy to mild hypertrophy, which indicates that adenoids have a tendency to atrophy and the symptoms are improved.
Clinical case 3:
wang, woman, age: the diagnosis of the adenoids is confirmed to be obviously hypertrophied by 9-menstruation nasopharyngeal CT in 2020 by the outpatient clinic of otorhinolaryngology department of a certain Guangzhou hospital in age 5, and the diagnosis is reported in detail that thickened soft tissue shadow can be seen on the back wall of the top of a nasopharyngeal cavity, the edge is smooth, and the thickness is about 1.2CM. Abnormal density shadow is seen in the maxillary sinus cavity and the sphenoid sinus right atrium on both sides, and the sinus wall bone is not damaged. No obvious abnormalities were seen in the remaining sinuses. When a patient sleeps at night, the patch prepared in the embodiment 3 of the invention is used, the patient goes to a hospital for a double-examination after 3 months, the nasopharyngeal part CT diagnosis in 12-menstruation period in 2020 shows that no abnormality exists, and the diagnosis details report that thickened soft tissue shadow can be seen on the top and back wall of the nasopharyngeal cavity, the edge is smooth, and the thickness is about 0.6CM. Abnormal density shadow is seen in the maxillary sinus cavity and the sphenoid sinus right atrium on both sides, and the sinus wall bone is not damaged. No obvious abnormality was seen in the remaining sinuses. That is, the soft tissue thickness of the nasopharyngeal cavity top was from 1.2CM to 0.6CM, and adenoids were completely removed after the patient used the patch prepared in example 3 of the present invention.
Clinical case 4:
zhao somebody, male, age: after 6 years of age, the adenoid body is confirmed to be remarkably hypertrophied by 9-month nasopharynx lateral tablets in outpatient clinic of nasopharynx and laryngology department of Guizhou hospital in 2020, the diagnosis is reported in detail as thickening of the nasopharynx top posterior wall, the corresponding airway is slightly narrowed, and the ratio (A/N ratio) of the distance between the most salient point of the slope outer edge and the pharynx posterior wall to the distance between the slope outer edge and the airway front edge is 0.81. In morning and evening, adenosylmethionine is used in Zhongxiao, a hospital is retested after 2 months, and after examination on a nasopharynx lateral tablet in 11 months in 2020, the diagnosis is detailed and reported that the nasopharynx top back wall is thickened, the corresponding airway is narrowed, and the ratio of the distance between the outer edge of the slope and the most salient point of the pharynx back wall to the distance between the outer edge of the slope and the front edge of the airway is 0.66. Although adenoids are still diagnosed as hypertrophied, the A/N ratio of the patch prepared in example 3 of the present invention is from 0.81 to 0.66, indicating that adenoids tend to atrophy, and that adenoids undergo a change from marked hypertrophy to mild hypertrophy with reduced symptoms.
The present invention should be considered as limited only by the preferred embodiments and not by the specific details, since modifications, equivalents, and improvements made within the spirit and scope of the invention are intended to be included therein.
Claims (9)
1. A traditional Chinese medicine composition for treating adenoidal hypertrophy is characterized by comprising the following components in parts by weight: 15-25 parts of radix scrophulariae, 15-25 parts of fried bighead atractylodes rhizome, 20-35 parts of poria cocos, 15-30 parts of curcuma zedoary, 15-30 parts of rhizoma acori graminei, 20-35 parts of charred medicated leaven, 10-25 parts of bamboo shavings, 10-25 parts of semen lepidii, 10-25 parts of rhizoma alismatis, 10-30 parts of scutellaria baicalensis, 10-25 parts of flos magnoliae, 20-35 parts of salvia miltiorrhiza, 15-30 parts of cortex albiziae, 15-30 parts of raw oyster and 15-20 parts of lance asiabell root.
2. The traditional Chinese medicine composition for treating adenoid hypertrophy as claimed in claim 1, wherein the roasted rhizoma atractylodis macrocephalae, the poria cocos, the radix scrophulariae and the lance asiabell root are taken as monarch drugs; the rhizoma acori graminei, the charred medicated leaven, the bamboo shavings, the pepperweed seed and the rhizoma alismatis are taken as ministerial drugs; the scutellaria baicalensis and the magnolia flower are used as adjuvant drugs; the salvia miltiorrhiza, the silktree albizzia bark, the zedoary and the raw oyster shell are taken as adjuvant medicaments.
3. The traditional Chinese medicine composition for treating adenoidal hypertrophy according to claim 1, wherein the composition comprises the following components in parts by weight: 20 parts of radix scrophulariae, 23 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos, 20 parts of curcuma zedoary, 25 parts of rhizoma acori graminei, 30 parts of charred medicated leaven, 18 parts of bamboo shavings, 19 parts of semen lepidii, 22 parts of rhizoma alismatis, 26 parts of scutellaria baicalensis, 17 parts of magnolia flower, 23 parts of salvia miltiorrhiza, 19 parts of cortex albiziae, 22 parts of raw oyster and 18 parts of lance asiabell root.
4. The patch for the treatment of adenoid hypertrophy of claim 1, wherein said patch comprises a Chinese medicinal composition of claim 1.
5. The patch for treating adenoid hypertrophy of claim 4, wherein the patch is for application to a patient's acupoint selected from one or more of the Yongquan, shenque, tiantu, and Dazhui acupoints.
6. The method of preparing a patch for the treatment of adenoids according to claim 4, comprising the steps of:
s1: respectively and independently crushing figwort root, fried bighead atractylodes rhizome, poria cocos, curcuma zedoary, rhizoma acori graminei, scorched medicated leaven, bamboo shavings, semen lepidii, rhizoma alismatis, scutellaria baicalensis, magnolia flower, salvia miltiorrhiza, cortex albiziae, raw oyster shell and lance asiabell root into 80-mesh medicinal powder for later use;
s2: pulverizing the powder in S1 to 200-400 mesh powder with a low-temperature ultrafine pulverizer for later use;
s3: uniformly mixing the medicinal powder in the step S2 to form ointment;
s4: and (4) coating the ointment in the step (S3) on a backing material, cutting into slices, covering a protective film on the slices, and packaging to obtain the patch.
7. The preparation method of the patch for treating adenoid hypertrophy as claimed in claim 6, wherein pure honey is further added in S3, and the honey is added into the medicinal powder and mixed evenly.
8. The preparation method of the patch for treating adenoid hypertrophy as claimed in claim 6, wherein a penetrant is further added into S3, and the penetrant is added into the medicinal powder and mixed evenly.
9. The method of making a patch for the treatment of adenoids hypertrophy of claim 8, wherein said osmotic agent is azone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211369749.4A CN115463200B (en) | 2022-11-03 | 2022-11-03 | Traditional Chinese medicine composition and patch for treating adenoid hypertrophy and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211369749.4A CN115463200B (en) | 2022-11-03 | 2022-11-03 | Traditional Chinese medicine composition and patch for treating adenoid hypertrophy and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115463200A true CN115463200A (en) | 2022-12-13 |
| CN115463200B CN115463200B (en) | 2024-02-02 |
Family
ID=84338205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211369749.4A Active CN115463200B (en) | 2022-11-03 | 2022-11-03 | Traditional Chinese medicine composition and patch for treating adenoid hypertrophy and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115463200B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116870122A (en) * | 2023-08-22 | 2023-10-13 | 长春中医药大学 | Traditional Chinese medicine composition for treating pediatric adenoid hypertrophy and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306751A (en) * | 2014-09-09 | 2015-01-28 | 宋永花 | Traditional Chinese medicine used for treating snoring |
| CN106890280A (en) * | 2015-12-21 | 2017-06-27 | 上海中医药大学附属龙华医院 | Chinese medicine composition, its extract, preparation method and application, the medicament containing it |
| CN112057600A (en) * | 2020-10-26 | 2020-12-11 | 北京沃德中医药研究院 | Traditional Chinese medicine component for treating adenoid tonsil hypertrophy of children and preparation method thereof |
-
2022
- 2022-11-03 CN CN202211369749.4A patent/CN115463200B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306751A (en) * | 2014-09-09 | 2015-01-28 | 宋永花 | Traditional Chinese medicine used for treating snoring |
| CN106890280A (en) * | 2015-12-21 | 2017-06-27 | 上海中医药大学附属龙华医院 | Chinese medicine composition, its extract, preparation method and application, the medicament containing it |
| CN112057600A (en) * | 2020-10-26 | 2020-12-11 | 北京沃德中医药研究院 | Traditional Chinese medicine component for treating adenoid tonsil hypertrophy of children and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 何玉华编著: "《22种常见病小儿推拿全搞定》", 山西科学技术出版社, pages: 113 - 116 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116870122A (en) * | 2023-08-22 | 2023-10-13 | 长春中医药大学 | Traditional Chinese medicine composition for treating pediatric adenoid hypertrophy and application thereof |
| CN116870122B (en) * | 2023-08-22 | 2024-04-05 | 长春中医药大学 | Traditional Chinese medicine composition for treating pediatric adenoid hypertrophy and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115463200B (en) | 2024-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1899550A (en) | External plaster for treating child cold type cough and preparing method | |
| CN104352587A (en) | Ointment for treating rhinitis | |
| CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
| CN105412858A (en) | Syrup and preparation method thereof | |
| CN115463200B (en) | Traditional Chinese medicine composition and patch for treating adenoid hypertrophy and preparation method thereof | |
| CN102228626B (en) | Traditional Chinese medicine for treating tinnitus and deafness | |
| CN101057942B (en) | External applied medicine ointment for treating diabetes foot and its preparing method | |
| CN103007175A (en) | Traditional Chinese medicine package for treating infantile diarrhea | |
| CN1301743C (en) | Chinese medicinal formula for treating chronic bronchitis | |
| CN104338050A (en) | Health care product capable of improving sleep quality | |
| CN104147388B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
| CN102488784A (en) | Traditional Chinese medicine composition for treating low back pain | |
| CN104721489A (en) | Chinese patent medicine for treating Parkinson disease and preparation method thereof | |
| CN101829248B (en) | Traditional Chinese medicine for treating goiter | |
| CN101380458B (en) | Traditional Chinese medicine for treating chronic and urgent cough and asthma and preparation method thereof | |
| CN103610896A (en) | Exogenous cough treatment traditional Chinese medicine | |
| CN102293941B (en) | Chinese medicinal composition for treating diabetes mellitus | |
| CN101085197A (en) | Vein relaxing capsule for treating chronic pharyngitis | |
| CN103893328A (en) | Traditional Chinese medicine pill used for treating hyperplasia of mammary glands | |
| CN101797316A (en) | Traditional Chinese medicine for treating hyperpyrexia and infantile convulsion and preparation method thereof | |
| CN102139062A (en) | Novel traditional Chinese medicine for treating pharyngitis and tonsillitis | |
| CN106389738A (en) | Traditional Chinese medicine granules for treating constipation | |
| CN105435042A (en) | Traditional Chinese medicine health care unguent | |
| CN1174767C (en) | Compsn. of Chinese traditional medicine for treating adenoids and its complicating disease | |
| CN117919354A (en) | A Chinese medicinal patch with cough and asthma relieving effects, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |